Showing results (111-120 of 251) with videos related to

Sort By:
Pageof 26
Onkologie|February 1, 1983
[Sequentially alternating chemotherapy of non-seminomatous testicular tumors with adriamycin/cisplatin and bleomycin/vinblastine. Therapeutic success and failure with respect to histology and tumor stages]J Schütte, K Bremer, N Niederle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalitiesM Sarbia, M Stahl, U Fink, et al.
Deutsche Medizinische Wochenschrift (1946)|April 19, 1985
[Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen]K Höffken, A Ippisch, R Pfeiffer, et al.
British Journal of Cancer|July 1, 1996
Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell linesU Klaassen, A Harstrick, N Schleucher, et al.
Deutsche Medizinische Wochenschrift (1946)|June 13, 1975
[New chemotherapy (adriamycin, belomycin and vincristin) of metastasizing malignant testicular teratoma (author's transl)]S Seeber, W M Gallmeier, K Höffken, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
DNA repair and cellular resistance to alkylating agents in chronic lymphocytic leukemiaM R Müller, C Buschfort, J Thomale, et al.
Cancer Research|August 15, 1994
Capacity of individual chronic lymphatic leukemia lymphocytes and leukemic blast cells for repair of O6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcomeM R Müller, F Seiler, J Thomale, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitroU Vanhoefer, A Harstrick, H Wilke, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1988
Phase I study of pirarubicinA A Miller, M E Scheulen, U R Kleeberg, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
Paclitaxel and UFT plus oral calcium folinate in pretreated metastatic breast cancerU Klaassen, D Borquez, S Lang, et al.
Pageof 26